Guest pass · Create my free accountCreate my free accountGuest pass · Create free accountCreate free accountCreate my free accountCreate my free accountCreate free accountCreate free account
Biotech: 283 stocks
Biotech companies develop new drugs, many with no drug on sale yet. One trial result or FDA decision can move a stock, and many raise cash by selling new shares.
As of Monday's close · Live for Pro members at the open
We do the work for you.Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind.Pro members see it live, with prices that refresh every 2.5 seconds while the market is open.
See all 283 stocks rankedSee it live, free until Wednesday morning.No account. No card.Then keep going with a free account.
Tested. Our top-scored stocks returned 2.2x the average stock over the next month. How we tested it ›
We do the work for you.Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind.Pro members see it live, with prices that refresh every 2.5 seconds while the market is open.
See all 283 stocks rankedSee it live, free until Wednesday morning.No account. No card.Then keep going with a free account.
Biotech stocks were nearly flat from Oct 19 to Oct 26, a median rise of 0.1% (283 stocks); the S&P 500 fell 0.1%. No single story: 144 of 283 rose and 138 fell this week.
The biggest by market cap are Amgen (AMGN) at $242B, Gilead Sciences (GILD) at $195B, and Vertex Pharmaceuticals (VRTX) at $136B.
Which companies in biotech does Breakaway rank highest?+
Halozyme Therapeutics (HALO) 21, Amneal Pharmaceuticals (AMRX) 20, and Rigel Pharmaceuticals (RIGL) 19, the highest Quality Scores of the 283. Breakaway ranks every stock by its Quality Score, which reads each company's numbers and its chart; the ranking is information, not advice, and each stock's page shows the reasons behind its score.
Our top-scored stocks' record: Oct 2021 to Sep 2026, before costs; recorded live since Sep 9 2026.
Breakaway publishes impersonal securities research and analytical tools: one formula, the same score for everyone. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security.
Market data from a licensed vendor. The age of every quote is shown on the page.
May we record how this site is used and measure our ads? Privacy policy
This browser is too old to show this page right. Update it, or open this page in Safari or Chrome.